Denver, CO, United States of America

Fenneke G Joslin


Average Co-Inventor Count = 5.6

ph-index = 3

Forward Citations = 195(Granted Patents)


Company Filing History:


Years Active: 1991-2005

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Fenneke G Joslin: Innovator in Interleukin-1 Inhibitors

Introduction

Fenneke G Joslin is a prominent inventor based in Denver, CO (US). She has made significant contributions to the field of biochemistry, particularly in the development of interleukin-1 inhibitors. With a total of 3 patents, her work has the potential to impact therapeutic approaches for various inflammatory conditions.

Latest Patents

Fenneke's latest patents include groundbreaking inventions related to nucleic acids encoding interleukin-1 inhibitors. One of her notable patents discloses compounds with the general formula R—X—R, where R and R are biologically active groups, at least one of which is polypeptidic. The non-peptidic polymeric group X plays a crucial role in the functionality of these compounds. Additionally, her patents cover interleukin-1 inhibitors, compositions comprising these inhibitors, and methods for treating patients through their administration.

Career Highlights

Throughout her career, Fenneke has worked with various organizations, including Synergen, Inc. Her innovative research has positioned her as a key figure in the development of therapeutic agents targeting interleukin-1, which is critical in managing inflammatory responses.

Collaborations

Fenneke has collaborated with notable professionals in her field, including Charles H Hannum and Robert C Thompson. These partnerships have further enhanced her research and contributed to the advancement of her inventions.

Conclusion

Fenneke G Joslin's contributions to the field of interleukin-1 inhibitors exemplify her dedication to innovation in biochemistry. Her patents and collaborations reflect her commitment to advancing medical science and improving patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…